🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase II, open-label, multicenter, randomized controlled trial exploring ...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-09
Trial ID
NCT07150208
Treatments Being Tested
DELTA-2 is a phase 1 clinical trial to evaluate the safety, feasibility, an...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-08
Trial ID
NCT05393635
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of giv...
Status
Completed
Location
Thomas Street Clinic C605-020 CRS
Start Date
1998-05
Trial ID
NCT00000825
Treatments Being Tested
ALT-101 is a first-in-human Phase 1 clinical trial testing a new antibody d...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2026-06-01
Trial ID
NCT07586618
Treatments Being Tested
This will be a Phase 1 Open-label, dose escalation and expansion study of M...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2021-05-27
Trial ID
NCT04795713
Treatments Being Tested
The primary purpose of this study is to determine the antitumor activity of...
Status
Active Not Recruiting
Location
Arizona Oncology
Start Date
2020-03-10
Trial ID
NCT04225117
Treatments Being Tested
The purpose of this study is to determine the recommended dose of CMC544 ad...
Status
Completed
Location
AZ Sint Jan
Start Date
2012-12
Trial ID
NCT01562990
Treatments Being Tested
BRF116056 is the first clinical experience with GSK2118436, a BRAF inhibito...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-05-11
Trial ID
NCT01582997
Treatments Being Tested
Phase III multicentric, open-label, randomized study The main objective is...
Status
Recruiting
Location
Chu Dijon Bourgogne
Start Date
2026-05-07
Trial ID
NCT06197425
Breast cancer is the second most common invasive malignancy and the leading...
Status
Terminated
Location
Hospital del Mar
Start Date
2022-05-11
Trial ID
NCT05385705
Treatments Being Tested